Literature DB >> 8277283

HPLC is an effective and fast method for analysis of viral proteins: a study of encephalomyocarditis virus mutants differing in pathogenicity.

A Zimmermann1, T Mertens, A Schulz, J P Kruppenbacher, B Nelsen-Salz, H J Eggers.   

Abstract

We investigated the use of HPLC in analysis of picornavirus variants by comparing structural polypeptides of three stable mutants of encephalomyocarditis virus (EMCV). The variants are known to differ in their pathogenicity for mice: plaque variant 2 (PV2) is diabetogenic, PV7 is non-diabetogenic and PV21 induces a generalized lethal infection. We first used HPLC to separate the structural proteins at high purity levels. Detailed analysis of these structural proteins by HPLC-peptide mapping revealed differences in all four viral proteins of PV21 as compared with mutants PV2 and PV7. A single amino acid exchange was found in viral protein 1 between PV2 and PV7. Altered peaks were identified by calculating retention times of tryptic peptides using sequence data and a computer program. Since peak alterations could be attributed to the observed amino acid exchanges, the results correlate well with cDNA sequencing data. Thus HPLC proved to be a useful and fast tool for primary or additional characterization of picornavirus variants at the level of whole virus proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8277283     DOI: 10.1099/0022-1317-74-12-2759

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  2 in total

1.  Molecular cloning and sequence determination of the complete genome of the virulent echovirus 9 strain barty.

Authors:  H Zimmermann; H J Eggers; B Nelsen-Salz
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

2.  Infectious cDNA clones of echovirus 12 and a variant resistant against the uncoating inhibitor rhodanine differ in seven amino acids.

Authors:  W Kraus; H Zimmermann; A Zimmermann; H J Eggers; B Nelsen-Salz
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.